Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (HOSE: DBD)
Health Care · Pharmaceuticals · VN
₫49,200.00
-0.10% today · -8.0% 1Y
Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (HOSE: DBD) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $178.00M.
Over the last twelve months the share price has lost 8.0%, trading between 46.60K and 54.60K.
Tweenvest scores Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company across four factors: quality 84/100, value 56/100, growth 50/100, dividend 90/100. Its strongest factor is dividend.
DBD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $178.00M
- Revenue (TTM)
- $71.03M
- P/E
- 18.66
- EPS
- 2,636.77
- Dividend yield
- 4.07%
- Beta (5Y)
- -0.01
- 52-week high
- ₫54,600.00
- 52-week low
- ₫46,600.00
- Avg volume (3M)
- —
- Shares outstanding
- 94.49M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.